Bpc-157 + Tb-500
Peptide therapy: benefits, side effects, cost and protocols
BPC-157 + TB-500 is a combination stack of Body Protection Compound-157 and Thymosin Beta-4, used together for their complementary tissue repair mechanisms. BPC-157 promotes angiogenesis while TB-500 enhances cell migration and repair. Both were removed from FDA compounding in 2024.
Sources: FDA / PubMed / ClinicalTrials.gov View
Spec sheet
- FDA status
- Banned from Compounding March 2024 Both components (BPC-157 and TB-500) removed from FDA compounding nomination list.
- Evidence
- Anecdotal
Mechanism
How Bpc-157 + Tb-500 works
Combines BPC-157's angiogenesis and gut-healing properties with TB-500's actin regulation and systemic healing capabilities.
FAQ
Bpc-157 + Tb-500 questions
What is BPC-157 + TB-500?
A popular combination blend of two leading tissue repair peptides, BPC-157 and TB-500, often used together in research for synergistic healing effects.
How does BPC-157 + TB-500 work?
Combines BPC-157's angiogenesis and gut-healing properties with TB-500's actin regulation and systemic healing capabilities.
Is BPC-157 + TB-500 legal to buy?
BPC-157 + TB-500 is sold as a research chemical for laboratory use only. It is not approved for human use by the FDA. Regulations vary by jurisdiction.
Where can I buy BPC-157 + TB-500?
BPC-157 + TB-500 has mixed availability - it can be found through both compounding pharmacies (with prescription) and research suppliers.
What category does BPC-157 + TB-500 belong to?
BPC-157 + TB-500 is primarily classified as a tissue repair & healing peptide. Peptides studied for their potential in wound healing, tendon/ligament repair, gut healing, and general tissue regeneration.
What are the research benefits of BPC-157 + TB-500?
BPC-157 + TB-500 has been studied for: Enhanced tissue repair, Synergistic healing, Recovery support. Popular recovery blend combining two top healing peptides.
News
Bpc-157 + Tb-500 in the news
Are Peptides Legal Now? What the New HHS Policy Really Means - Hone Health
Hone Health / 5 days ago
Peptide Therapy: What the Science Shows About BPC-157, TB-500 and Wolverine Stacks - Cedars-Sinai
Cedars-Sinai / 3 months ago
The compounding problem of peptides - Johns Hopkins University
Johns Hopkins University / 2 months ago
Peptides: Doctors explain the benefits, risks and FDA concerns - UCHealth
UCHealth / 4 months ago
FDA panel narrowly backs unapproved peptide drugs favored by RFK Jr. and wellness influencers - AP News
AP News / 4 months ago
News aggregated via Google News. Inclusion does not imply endorsement.
Considering Bpc-157 + Tb-500?
The 2-minute quiz matches you with licensed providers who offer it. A clinician decides if it fits.